The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
No Alterations in the Frequency of FOXP3+ Regulatory T-Cells in Type 1 Diabetes
Open accessAbstract
Regulatory T-cells (Tregs) play a critical role in maintaining dominant peripheral tolerance. Previous characterizations of Tregs in type 1 diabetes have used antibodies against CD4 and α-chain of the interleukin-2 receptor complex (CD25). This report extends those investigations by the addition of a more lineage-specific marker for Tregs, transcription factor forkhead box P3 (FOXP3), in subjects with type 1 diabetes, their first-degree relatives, and healthy control subjects. With inclusion of this marker, two predominant populations of CD4+CD25+ T-cells were identified: CD4+CD25+FOXP3+ as well as CD4+FOXP3− T-cells expressing low levels of CD25 (CD4+CD25LOWFOXP3−). In all study groups, the frequency of CD4+CD25+FOXP3+ cells was age independent, whereas CD4+CD25LOWFOXP3− cell frequencies strongly associated with age. In terms of additional markers for delineating cells of Treg lineage, FOXP3+ cells were CD127− to CD127LOW whereas CD25+ cells were less restricted in their expression of this marker, with CD127 expressed across a continuum of levels. Importantly, no differences were observed in the frequency of CD4+CD25+FOXP3+ T-cells in individuals with or at varying degrees of risk for type 1 diabetes. These investigations suggest that altered peripheral blood frequencies of Tregs, as defined by the expression of FOXP3, are not specifically associated with type 1 diabetes and continue to highlight age as an important variable in analysis of immune regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Sakaguchi, S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,306
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606
Self-citationRegulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
A function for interleukin 2 in Foxp3-expressing regulatory T cells
Fontenot, J. D., Rasmussen, J. P., Gavin, M. A., & Rudensky, A. Y. (2005) · Nature Immunology · doi:10.1038/ni1263 · Cited by 1,819
Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512 · cited 2×
“The surface marker CD127 (IL-7 receptor -chain) appears to be expressed at the highest levels on effector T-cells, whereas functional Tregs are CD127 or negative (17,18).”
BackgroundType 1 diabetes: new perspectives on disease pathogenesis and treatment
Atkinson, M. A., & Eisenbarth, G. S. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05415-0 · Cited by 1,491
Self-citationSetoguchi, R., Hori, S., Takahashi, T., & Sakaguchi, S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041982 · Cited by 1,235
Ziegler, S. F. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090547 · Cited by 922
Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes
Lindley, S., Dayan, C. M., Bishop, A., Roep, B. O., Peakman, M., & Tree, T. I. M. (2005) · Diabetes · doi:10.2337/diabetes.54.1.92 · Cited by 861
Zorn, E., Nelson, E. A., Mohseni, M., Porcheray, F., Kim, H., Litsa, D., Bellucci, R., Raderschall, E., Canning, C., Soiffer, R. J., et al. (2006) · Blood · doi:10.1182/blood-2006-02-004747 · Cited by 740
Homeostatic Expansion of T Cells during Immune Insufficiency Generates Autoimmunity
King, C., Ilic, A., Koelsch, K., & Sarvetnick, N. (2004) · Cell · doi:10.1016/s0092-8674(04)00335-6 · Cited by 670
Multiple immuno-regulatory defects in type-1 diabetes
Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin‐Su, K., Ten, S., Sanz, M. M., Exley, M. A., Wilson, B., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13605 · Cited by 640
The NOD mouse model of type 1 diabetes: As good as it gets?
Atkinson, M. A., & Leiter, E. H. (1999) · Nature Medicine · doi:10.1038/9442 · Cited by 588
Self-citationMultiple immuno-regulatory defects in type-1 diabetes
Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin-Su, K., Ten, S., Sanz, M., Exley, M., Wilson, B., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213605 · Cited by 566
Vukmanovic-Stejic, M., Zhang, Y., Cook, J. E., Fletcher, J. M., McQuaid, A., Masters, J. E., Rustin, M. H. A., Taams, L. S., Beverley, P. C. L., Macallan, D. C., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28941 · Cited by 480
MHC Class II Expression Identifies Functionally Distinct Human Regulatory T Cells
Baecher-Allan, C., Wolf, E., & Hafler, D. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4622 · Cited by 421
Functional Defects and the Influence of Age on the Frequency of CD4+CD25+ T-Cells in Type 1 Diabetes
Brusko, T. M., Wasserfall, C. H., Clare-Salzler, M. J., Schatz, D. A., & Atkinson, M. A. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1407 · Cited by 398
Self-citationHuman CD4+CD25+ regulatory T cells
Baecher-Allan, C. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.12.005 · Cited by 385
Vella, A., Cooper, J. D., Lowe, C. E., Walker, N., Nutland, S., Widmer, B., Jones, R., Ring, S. M., McArdle, W., Pembrey, M. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429843 · Cited by 352
L-selectin: mechanisms and physiological significance of ectodomain cleavage
Smalley, D. M., & Ley, K. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00354.x · Cited by 233
CD4+CD25+Foxp3+ T Cells and CD4+CD25−Foxp3+ T Cells in Aged Mice
Nishioka, T., Shimizu, J., Iida, R., Yamazaki, S., & Sakaguchi, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6586 · Cited by 218
CD4+CD25high regulatory T cells in human autoimmune diabetes
Putnam, A. L., Vendrame, F., Dotta, F., & Gottlieb, P. A. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2004.11.004 · Cited by 205
Self-citationTsaknaridis, L., Spencer, L., Culbertson, N., Hicks, K., LaTocha, D., Chou, Y. K., Whitham, R. H., Bakke, A., Jones, R. E., Offner, H., et al. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10766 · Cited by 197
Type 1 diabetes genes and pathways shared by humans and NOD mice
Wicker, L. S., Clark, J., Fraser, H. I., Garner, V. E. S., González-Muñoz, A., Healy, B. C., Howlett, S., Hunter, K. M. D., Rainbow, D., Rosa, R. L., et al. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.09.009 · Cited by 153
Lyons, P., Armitage, N., Argentina, F., Denny, P., Hill, N. J., Lord, C. J., Wilusz, M. B., Peterson, L. B., Wicker, L. S., & Todd, J. A. (2000) · Genome Research · doi:10.1101/gr.10.4.446 · Cited by 139
Fueling regulation: IL-2 keeps CD4+ Treg cells fit
Maloy, K. J., & Powrie, F. M. (2005) · Nature Immunology · doi:10.1038/ni1105-1071 · Cited by 137
Regulatory T cells in human disease and their potential for therapeutic manipulation
Taams, L. S., Palmer, D. B., Akbar, A. N., Robinson, D. S., Brown, Z., & Hawrylowicz, C. M. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02348.x · Cited by 136
Are regulatory T-cells linked with aging?
Dejaco, C., Duftner, C., & Schirmer, M. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.01.008 · Cited by 120
Molecular aspects of regulatory T cell development
Fontenot, J. D., & Rudensky, A. Y. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.12.002 · Cited by 61
Giordano, C. S. D. S., Pantò, F., Caruso, C., Modica, M. A., Zambito, A. M., Sapienza, N., Amato, M. P., & Galluzzo, A. (1989) · Diabetes · doi:10.2337/diab.38.3.310 · Cited by 54
Interleukin-2 Signaling and the Maintenance of Self-Tolerance
Nelson, B. H. (2001) · KARGER eBooks · doi:10.1159/000060549 · Cited by 52
Autoimmune Diseases as the Loss of Active “Self‐Control”
Bach, J. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1254.017 · Cited by 46
Davoodi‐Semiromi, A., Laloraya, M., Kumar, P. G., Purohit, S. B., Jha, R. K., & She, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312110200 · Cited by 42
Roncarolo, M., Zoppo, M., Bacchetta, R., Gabiano, C., Sacchetti, C., Cerutti, F., & Tovo, P. (1988) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(88)90094-3 · Cited by 34
Litherland, S. A., Grebe, K. M., Belkin, N. S., Paek, E., Elf, J. L., Atkinson, M. A., Morel, L. M., Clare-Salzler, M. J., & MCDUFFIE, M. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4561 · Cited by 29
Self-citationImbalance of the interleukin 2 system in children with IDDM
Tomoda, T., Kurashige, T., & Taniguchi, T. (1994) · Diabetologia · doi:10.1007/s001250050135 · Cited by 17
Cited by
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022
Sun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,014
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases
Buckner, J. H. (2010) · Nature Reviews Immunology · doi:10.1038/nri2889 · Cited by 789
Foxp3+ regulatory T cells: differentiation, specification, subphenotypes
Feuerer, M., Hill, J. A., Mathis, D., & Benoist, C. (2009) · Nature Immunology · doi:10.1038/ni.1760 · Cited by 507
Vitamin D’s Effect on Immune Function
Martens, P.-J., Gysemans, C., Verstuyf, A., & Mathieu, C. (2020) · Nutrients · doi:10.3390/nu12051248 · Cited by 449
Metadata
- Authors
- Brusko, T., Wasserfall, C., McGrail, K., Schatz, R., Viener, H. L., Schatz, D., Haller, M., Rockell, J., Gottlieb, P., Clare-Salzler, M., & Atkinson, M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2007-03-01
- Volume
- 56
- Issue
- 3
- Pages
- 604-612
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2116961420
- Cited by
- 253
- References
- 38
- FWCI
- 8.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.